Safety and Effectiveness of the Genous™ Endothelial Progenitor Cell-Capture Ste...

• Autor(es): Pereira-da-Silva, T ; Bernardes, L ; Cacela, D ; Fiarresga, A ; Sousa, L ; Patrício, L ; Cruz Ferreira, R
• Data: 2013
• Identificador Persistente: http://hdl.handle.net/10400.17/1549
• Origem: Repositório do Centro Hospitalar de Lisboa Central, EPE
• Assunto(s): Células Endoteliais; Stent; Angioplastia; HSM CAR; Angioplastia Coronária de Balão; Angiografia Coronária; Electrocardiografia; Enfarte do Miocárdio; Literatura de Revisão como Assunto; Células-Tronco; Trombose; Efeitos Adversos; Resultado de Tratamento
• Tipo de Documento: Artigo
• Idioma: Inglês

Descrição

PURPOSE: The Genous™ stent (GS) is designed to accelerate endothelization, which is potentially useful in the pro-thrombotic environment of ST-elevation acute myocardial infarction (STEMI). We aimed to evaluate the safety and effectiveness of the GS in the first year following primary percutaneous coronary intervention (PCI) and to compare our results with the few previously published studies. METHODS AND MATERIALS: All patients admitted to a single center due to STEMI that underwent primary PCI using exclusively GS, between May 2006 and January 2012, were enrolled. The primary study endpoints were major adverse cardiac events (MACEs), defined as the composite of cardiac death, acute myocardial infarction and target vessel revascularization, at one and 12months. RESULTS: In the cohort of 109 patients (73.4% male, 59 ±12years), 24.8% were diabetic. PCI was performed in 116 lesions with angiographic success in 99.1%, using 148 GS with median diameter of 3.00mm (2.50-4.00) and median length of 15mm (9-33). Cumulative MACEs were 2.8% at one month and 6.4% at 12months. Three stent thromboses (2.8%), all subacute, and one stent restenosis (0.9%) occurred. These accounted for the four target vessel revascularizations (3.7%). At 12months, 33.9% of patients were not on dual antiplatelet therapy. CONCLUSIONS: GS was safe and effective in the first year following primary PCI in STEMI, with an apparently safer profile comparing with the previously published data. SUMMARY: We report the safety and effectiveness of the Genous™ stent (GS) in the first year following primary percutaneous coronary intervention in ST-elevation acute myocardial infarction. A comprehensive review of the few studies that have been published on this subject was included and some suggest a less safe profile of the GS. Our results and the critical review included may add information and reinforce the safety and effectiveness of the GS in ST-elevation in acute myocardial infarction.